Glass House Brands (GLAS) Assets Average (2021 - 2026)
Glass House Brands (GLAS) posted quarterly Assets Average of $322.0 million for Q1 2026, up 3.51% year-over-year from $311.0 million in Q1 2025, and up 0.87% quarter-over-quarter from $319.2 million in Q4 2025.
Glass House Brands (GLAS) Assets Average (2021 - 2026) Analysis & Trends
Glass House Brands (GLAS) has reported Assets Average for 6 consecutive years, with $322.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Assets Average rose 3.51% year-over-year to $322.0 million; the TTM figure through Mar 2026 stood at $322.0 million (up 3.51% YoY), while the FY2025 annual figure was $314.5 million, up 2.41% from the prior year.
- Assets Average rose to $322.0 million in Q1 2026 per GLAS's latest filing, from $319.2 million in the prior quarter.
- Across five years, Assets Average topped out at $350.1 million in Q4 2022 and bottomed at $139.4 million in Q1 2022.
- Historically, Assets Average has averaged $308.8 million across 5 years, with a median of $322.0 million in 2026.
- On a YoY basis, Assets Average climbed as much as 164.95% in 2022 and fell as far as 80.56% in 2022.
- Glass House Brands' Assets Average stood at $350.1 million in 2022, then retreated by 7.83% to $322.7 million in 2023, then dropped by 3.43% to $311.6 million in 2024, then grew by 2.43% to $319.2 million in 2025, then rose by 0.87% to $322.0 million in 2026.
- Business Quant data shows GLAS's Assets Average at $322.0 million in Q1 2026, $319.2 million in Q4 2025, and $327.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | 43.72 Bn |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | 39.95 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 15.12 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 98.59 Bn |
| 5 | United Therapeutics | 22.19 Bn | 19.53 Bn | 683.80 Mn | 6.97 Bn |
| 6 | Viatris | 18.68 Bn | 17.79 Bn | 1.46 Bn | 35.94 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 5.13 Bn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 13.39 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | 5.97 Bn |
| 10 | Glass House Brands | 830.21 Mn | 811.66 Mn | 15.77 Mn | 319.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 321.96 Mn |
| Dec 31, 2025 | 319.19 Mn |
| Sep 30, 2025 | 327.19 Mn |
| Jun 30, 2025 | 323.08 Mn |
| Mar 31, 2025 | 311.05 Mn |
| Dec 31, 2024 | 311.62 Mn |
| Sep 30, 2024 | 309.29 Mn |
| Jun 30, 2024 | 300.55 Mn |
| Mar 31, 2024 | 299.51 Mn |
| Dec 31, 2023 | 322.68 Mn |
| Sep 30, 2023 | 333.10 Mn |
| Jun 30, 2023 | 324.65 Mn |
| Mar 31, 2023 | 337.66 Mn |
| Dec 31, 2022 | 350.09 Mn |
| Sep 30, 2022 | 328.40 Mn |
| Jun 30, 2022 | 290.20 Mn |
| Mar 31, 2022 | 139.43 Mn |
| Dec 31, 2021 | 132.14 Mn |
| Sep 30, 2021 | 231.02 Mn |
| Jun 30, 2021 | 459.60 Mn |